Injection administration features of the patients who self-administer subcutaneous immunomodulator injection and the injection site reactions Kendi kendine subkutan İmmünomodülatör enjeksiyon uygulayan hastalari{dotless}n enjeksiyon uygulama özellikleri ve enjeksiyon bölgesi reaksiyonlari{dotless}
Turk Noroloji Dergisi, cilt.20, sa.1, ss.7-12, 2014 (Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 20 Sayı: 1
- Basım Tarihi: 2014
- Doi Numarası: 10.4274/tnd.15010
- Dergi Adı: Turk Noroloji Dergisi
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.7-12
- Anahtar Kelimeler: Multiple sclerosis, injection site reactions, immunomodulator treatment
- Sağlık Bilimleri Üniversitesi Adresli: Hayır
Özet
Objective: This study aims at examining the injection administration features of the patients with multiple sclerosis who self-administer subcutaneous immunomodulator injection, and the injection site reactions they experience. Material and Method: A total of 50 patients who fit the inclusion criteria for the study and volunteered to participate were included in the sample. The data was collected by a questionnaire which was developed by the researchers and based on the literature. Results: In our study, 74% of the patients have reported at least one injection site reaction. Pain and redness were among the most common injection site reactions and the least common reactions were abscess and lipoatrophy. No statistical difference was found between the development of injection site reactions and injection administration features, types of the administered medications, administration period of the medications, and number of total injections. A statistically significant difference was observed between gender and the development of injection site reactions. Conclusion: Injection administration features that were included in the study were not effective factors in terms of the injection site reactions. Injection site reactions were more common in women than in men.